We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Refurbished Medical Equipment Market Forecast at USD 8.45 Billion by 2017

By HospiMedica International staff writers
Posted on 26 Sep 2012
The global refurbished market has seen challenging and dynamic market conditions, but still remains strong, with a size of approximately USD 8.45 billion in 2017 and an estimated annual growth rate of 7.8% over the next five years. More...


A new market research report analyzed and studied the major market drivers, restraints, and opportunities in North America, Latin America, Europe, Asia, and the rest of the world. Refurbishing of medical device refers to restoring used equipment or systems into a condition of safety and effectiveness comparable to new including actions such as repair, rework, update, and replacement of worn parts with original parts.

Refurbished products do not change any product specification as remanufactured products do, thereby requiring no specific approval to market the refurbished products in different countries. Refurbished medical devices represent the aftermarket of used medical devices worldwide. As per conventional definition, refurbished devices hold a niche market that is different from remanufactured and used devices market.

The new report studied the global refurbished medical equipment market over the forecast period 2012-2017, published by market research company MarketsandMarkets (Dallas, TX, USA; www.marketsandmarkets.com). The global refurbished devices market is categorized into imaging-diagnostic-monitoring devices, minimally invasive surgical devices, radiation oncology devices, biotechnology instruments, and so others. Refurbished medical devices market is expected to grow at a more rapid rate with a compound annual growth rate (CAGR) of 7.8% from 2012 to 2017.

Cost-effective offerings of used branded products and enhanced access to replacement parts and repair technology are contributing to widespread adoption of the refurbished medical devices by healthcare institutions worldwide.

The refurbished medical equipment market is run by largely two kinds of players: original equipment manufacturers (OEMs) and third-party manufacturers. Major OEMs include GE Healthcare (UK), Siemens Healthcare (Germany), Philips Healthcare (The Netherlands), Stryker Corp. (US), Johnson & Johnson (US) and Toshiba Medical System (Japan), and third party vendors including Soma Technology (US), Agito Medical (Denmark), DMS Topline Medical (US), and First Source, Inc. (US).

MarketsandMarkets is a global market research and consulting company. The company publishes strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies worldwide.


Related Links:

MarketsandMarkets






Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.